Email Facebook Twitter

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money' Watch here

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018

Glaxosmithkline Share News (GSK)

Stock Market news at - RSS News Feeds

Share News for Glaxosmithkline (GSK)

Share Price: 1,297.50Bid: 1,297.00Ask: 1,297.50Change: -5.50 (-0.42%)Faller - Glaxosmithkline
Spread: 0.50Spread as %: 0.04%Open: 1,303.00High: 1,304.00Low: 1,295.50Yesterday’s Close: 1,303.00

UPDATE 1-U.S. FDA approves first two-drug HIV regimen from GSK

(Adds company comment, J&J reference, background)NEW YORK, Nov 21 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved the first two-
[21 Nov '17 23:18]

UPDATE 2-U.S. FDA approves first two-drug HIV regimen in win for GSK

* Juluca developed by GSK's majority-owned ViiV unit* Two-drug approach differentiates GSK from Gilead (Adds context on GSK drive to improve pharma sa
[21 Nov '17 23:18]

U.S. FDA approves first two-drug HIV regimen

NEW YORK, Nov 21 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes
[21 Nov '17 20:09]

EU drugs agency move to Amsterdam minimises likely staff losses

LONDON, Nov 20 (Reuters) - Amsterdam's success in winning the battle to host the European Medicines Agency (EMA), which is relocating from London beca
[20 Nov '17 18:11]

Endo unit cleared of liability in first testosterone replacement trial

By Tina BellonNEW YORK, Nov 16 (Reuters) - A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for
[16 Nov '17 21:21]

Europe approves GlaxoSmithKline's new triple lung drug

LONDON, Nov 16 (Reuters) - Europe has approved GlaxoSmithKline's new three-in-one inhaler for chronic lung disease, which the group hopes will help it
[16 Nov '17 07:43]

BUZZ-VBI Vaccines shoots up on BMO "outperform" initiation

** Shares of biotech firm VBI Vaccines Inc. jumped more than 8 pct on Weds after BMO initiated coverage at "outperform"** Broker sets $11 PT, about 15
[15 Nov '17 19:59]

UPDATE 2-Bayer hires new blood to stem 'Amazon effect' in consumer health

* Nestle's Heiko Schipper to join on March 1* To replace Erica Mann, who flagged 'Amazon effect'* Consumer unit grappling with switch to e-commerce* A
[15 Nov '17 09:07]

Share Price, Share Chat, Stock Market news at
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.